E-ISSN 2148-5607
RELATED ARTICLES
Editorial
Effects of a long-acting somatostatin analogue, lanreotide, on bile duct ligation-induced liver fibrosis in rats
(Turk J Gastroenterol 2010; 21: 287-292)
DOI: 10.4318/tjg.2010.0102
A large functional somatostatinoma in the pancreatic tail: Atypical CT appearances
(Turk J Gastroenterol 2009; 20: 291-294)
DOI: 10.4318/tjg.2009.0030
Protective effect of centrally-injected glucagon-like peptide-1 on reserpine-induced gastric mucosal lesions in rat: Possible mechanisms
(Turk J Gastroenterol 2006; 17: 1-6)
Comparison of terlipressin plus sclerotherapy with somatostatin plus sclerotherapy to control bleeding from esophageal varices in with Child C cirrhosis patients
(Turk J Gastroenterol 2001; 12: 95-99)
*Hemodynamic effect of somatostatin infusion in patients with non-variceal upper gastrointestinal bleeding
(Turk J Gastroenterol 2001; 12: 218-222)
The effect of somatostatin analogue (SMS 201-995) on renal function in patients with decompansated cirrhosis and helathy volunteers
(Turk J Gastroenterol 1996; 7: 22-26)
Gallbladder motility with the longer-acting somatostatin analogue (Octreoitide sms 201-995) in human
(Turk J Gastroenterol 1997; 8: 413-416)
Original Article
Prognostic value of somatostatin receptor-2 positivity in gastroenteropancreatic neuroendocrine tumors in reference to known prognostic factors
(Turk J Gastroenterol 2012; 23: 736-740)
DOI: 10.4318/tjg.2012.0476
Key Words
Authors
All
Reviewer's Corner
Author’s Corner
Survey
AVES | Copyright © 2019 Turkish Society of Gastroenterology | Latest Update: 09.05.2019